Search research articles
Contact Us
Filters
Showing results (121-130 of 578) with videos related to
Page
of 58
Sort By:
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Proteome Science
|
June 15, 2012
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 22, 2019
Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)
Lukas Dostalek, Ingo Runnebaum, Francesco Raspagliesi, et al.
Journal of Surgical Oncology
|
January 26, 2021
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer
Alexander Volcke, Els Van Nieuwenhuysen, Sileny Han, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fucikova, An Coosemans, Sandra Orsulic, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2016
Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study
Martin Koskas, Marie Fournier, Anke Vanderstraeten, et al.
Gynecologic Oncology
|
November 6, 2003
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth
Frederic Amant, Mona Liza Lottering, Annie Joubert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 29, 2012
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia
Sileny N Han, Frédéric Amant, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2016
Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer
Martin Koskas, Marta Jozwiak, Marie Fournier, et al.
Current Problems in Cancer
|
February 26, 2023
Tisotumab vedotin in recurrent or metastatic cervical cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Page
of 58
Search research articles
Search
Showing results (121-130 of 578) with videos related to
Sort By:
Page
of 58
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Proteome Science
|
June 15, 2012
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 22, 2019
Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)
Lukas Dostalek, Ingo Runnebaum, Francesco Raspagliesi, et al.
Journal of Surgical Oncology
|
January 26, 2021
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer
Alexander Volcke, Els Van Nieuwenhuysen, Sileny Han, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fucikova, An Coosemans, Sandra Orsulic, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2016
Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study
Martin Koskas, Marie Fournier, Anke Vanderstraeten, et al.
Gynecologic Oncology
|
November 6, 2003
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth
Frederic Amant, Mona Liza Lottering, Annie Joubert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 29, 2012
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia
Sileny N Han, Frédéric Amant, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2016
Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer
Martin Koskas, Marta Jozwiak, Marie Fournier, et al.
Current Problems in Cancer
|
February 26, 2023
Tisotumab vedotin in recurrent or metastatic cervical cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Page
of 58